Genetic mutations as causes of cancer
Dr Henry Lynch - Creighton University, Omaha, USA
Genetic mutations as causes of cancer ( Dr Henry Lynch - Creighton University, Omaha, USA )
25 Sep 2011
Early detection and prevention of melanoma (6/6)
European Post ASCO Meeting 2011 - Prof Axel Hauschild, Prof Michele Maio, Prof P...
Early detection and prevention of melanoma (6/6) ( European Post ASCO Meeting 2011 - Prof Axel Hauschild, Prof Michele Maio, Prof Paul Lorigan, Prof Dirk Schadendorf )
15 Aug 2011
Metastatic melanoma: changes in epidemiology and current standards of care (1/6)
European Post ASCO Meeting 2011 - Prof Axel Hauschild, Prof Michele Maio, Prof P...
Metastatic melanoma: changes in epidemiology and current standards of care (1/6) ( European Post ASCO Meeting 2011 - Prof Axel Hauschild, Prof Michele Maio, Prof Paul Lorigan, Prof Dirk Schadendorf )
15 Aug 2011
Recent advances in advanced melanoma: ipilimumab (2/6)
European Post ASCO Meeting 2011 - Prof Axel Hauschild, Prof Michele Maio, Prof P...
Recent advances in advanced melanoma: ipilimumab (2/6) ( European Post ASCO Meeting 2011 - Prof Axel Hauschild, Prof Michele Maio, Prof Paul Lorigan, Prof Dirk Schadendorf )
15 Aug 2011
Recent advances in advanced melanoma: BRAF inhibitors (3/6)
European Post ASCO Meeting 2011 - Prof Axel Hauschild, Prof Michele Maio, Prof P...
Recent advances in advanced melanoma: BRAF inhibitors (3/6) ( European Post ASCO Meeting 2011 - Prof Axel Hauschild, Prof Michele Maio, Prof Paul Lorigan, Prof Dirk Schadendorf )
15 Aug 2011
Combination of newer agents in advanced melanoma (4/6)
European Post ASCO Meeting 2011 - Prof Axel Hauschild, Prof Michele Maio, Prof P...
Combination of newer agents in advanced melanoma (4/6) ( European Post ASCO Meeting 2011 - Prof Axel Hauschild, Prof Michele Maio, Prof Paul Lorigan, Prof Dirk Schadendorf )
15 Aug 2011
Guidelines and recommendations for advanced melanoma (5/6)
European Post ASCO Meeting 2011 - Prof Axel Hauschild, Prof Michele Maio, Prof P...
Guidelines and recommendations for advanced melanoma (5/6) ( European Post ASCO Meeting 2011 - Prof Axel Hauschild, Prof Michele Maio, Prof Paul Lorigan, Prof Dirk Schadendorf )
15 Aug 2011
Improving pre-clinical experimental models to test anti cancer drugs
Dr Robert Kerbel - Sunnybrook Research Institute, University of Toronto, Canada
Improving pre-clinical experimental models to test anti cancer drugs ( Dr Robert Kerbel - Sunnybrook Research Institute, University of Toronto, Canada )
21 Jul 2011
Early stage molecular profiling
Prof Razelle Kurzrock - MD Anderson Cancer Centre, Houston, USA
Early stage molecular profiling ( Prof Razelle Kurzrock - MD Anderson Cancer Centre, Houston, USA )
19 Jul 2011
Emergence of ipilimumab and vemurafenib for melanoma
Prof Reinhard Dummer, Prof Claus Garbe, Dr Caroline Robert, Prof Jürgen Becker
Emergence of ipilimumab and vemurafenib for melanoma ( Prof Reinhard Dummer, Prof Claus Garbe, Dr Caroline Robert, Prof Jürgen Becker )
15 Jul 2011
The P-Medicine project; data sharing and integration for personalised medicine
Dr Simona Rossi - Swiss Institute for Bioinformatics, Lausanne, Switzerland
The P-Medicine project; data sharing and integration for personalised medicine ( Dr Simona Rossi - Swiss Institute for Bioinformatics, Lausanne, Switzerland )
14 Jul 2011
The changing landscape of melanoma therapies: indications of better patient outc...
Prof Alexander Eggermont, Dr Caroline Robert, Prof John Haanen and Prof Reinhard...
The changing landscape of melanoma therapies: indications of better patient outcome ( Prof Alexander Eggermont, Dr Caroline Robert, Prof John Haanen and Prof Reinhard Dummer )
24 Jun 2011